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Abstract
A 45-year-old lady presented acutely with pleuritic chest pain, haemoptysis,
and dyspnoea. Her background was signiﬁcant for a 1.4 cm renal angio-
myolipoma, and she was an ex-smoker without any relevant family history.
A computed tomography (CT) pulmonary angiogram was negative for a
pulmonary embolism but demonstrated diffuse cystic change throughout
both lungs. A bronchoscopy conﬁrmed a normal endobronchial tree, and
pulmonary function tests demonstrated moderate airways obstruction, with
reversibility and a normal diffusion capacity for carbon monoxide (DLCO).
A video-assisted thoracoscopic surgery (VATS) lung biopsy showed non-
caseating granulomas, and serum angiotensin converting enzyme (ACE)
was elevated consistent with a diagnosis of pulmonary sarcoidosis. Further
sectioning indicated focal areas that stained positive for Human Melanoma
Black 45 (HMB-45), conﬁrming lymphangioleiomyomatosis (LAM). A
diagnosis of cystic lung disease secondary to coexistent sarcoidosis and
LAM was made.
Introduction
This is an interesting case of coexistent lymphangioleio-
myomatosis (LAM) and pulmonary sarcoidosis in a
45-year-old lady. This case highlights important clinical,
radiological, and physiological features of both conditions
and suggests a potential shared disease mechanism.
Case Report
A 45-year-old lady was admitted with acute pleuritic chest
pain, haemoptysis, and dyspnoea. Her background was sig-
niﬁcant for a 1.4 cm left renal angiomyolipoma, myofascial
pain syndrome, and depression. Regular medications
included a combination umeclidinium and vilanterol
inhaler and escitalopram. She was an ex-smoker, with a
5 pack-year history, and denied any relevant family history
or occupational exposures. A computed tomography
(CT) pulmonary angiogram was performed on admission.
This was negative for a pulmonary embolism but demon-
strated diffuse, well-circumscribed cystic change through-
out both lungs, with no zonal predominance. Small foci of
ground-glass change were noted to be interspersed
between the cysts. There were no associated parenchymal
nodules or lymphadenopathy (Fig. 1). She was treated for
a lower respiratory tract infection and subsequently
referred to a tertiary centre for further assessment.
On review, she reported modiﬁed medical research
council (mMRC) grade 2 dyspnoea at baseline. A bron-
choscopy demonstrated a normal tracheobronchial tree,
and a bronchoalevolar lavage was auramine stain and
tuberculosis culture negative. Autoimmune serology was
also unremarkable. Pulmonary function tests demonstrated
forced expiratory volume in 1 second (FEV1) of 1.79 L
(62%), forced vital capacity (FVC) of 2.33 L (70%), a posi-
tive bronchodilator response of 390 mL (23%), and a nor-
mal DLCO. A diagnosis of tuberous sclerosis-associated
LAM was subsequently suspected based on a history of a
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renal angiomyolipoma and the presence of cortical tubers
on a screening magnetic resonance imaging (MRI) brain,
and a lung biopsy was requested for conﬁrmation. This ini-
tially demonstrated predominantly non-caseating granulo-
mas. She was also subsequently found to have an elevated
serum ACE of 68 U/L (reference range 0–45 U/L). A diag-
nosis of pulmonary sarcoidosis was made. Further biopsy
sectioning demonstrated focal areas of positive HMB-45
staining, conﬁrming LAM (Fig. 2). A diagnosis of cystic
lung disease secondary to coexistent sarcoidosis and LAM
was established.
Our patient was switched to an inhaled corticosteroid
and long-acting beta agonist given reversibility on spiro-
metric testing and is monitored closely in the respiratory
outpatient department. At present, she is not prescribed
targeted therapy for sarcoidosis or LAM and remains clini-
cally stable from a respiratory perspective.
Discussion
This case describes an incidental ﬁnding of coexistent
LAM and sarcoidosis in a female patient. LAM is an
orphan lung disease that classically effects females of child-
bearing age and may result in progressive cystic lung dis-
ease and respiratory failure. It can occur sporadically or in
association with tuberous sclerosis complex (TSC), and
both are characterized by mammalian target of rapamycin
(mTOR) dysregulation [1]. Alternatively, the incidence of
pulmonary sarcoidosis is highly variable and is associated
with a diverse clinical course and prognosis [2]. The prior-
ity in this case was to ascertain if abnormal clinical, physi-
ological, and radiological parameters were secondary to
LAM, sarcoidosis, cigarette smoking, asthma, or a combi-
nation of all four as this will have important implications
for future therapeutic choices if her respiratory disease
progresses.
Imaging in LAM typically demonstrates multiple, thin-
walled cysts with no signiﬁcant zonal predominance as
described in this case [1]. Cystic lung disease can also
Figure 1. A 45-year-old lady presents with acute dyspnoea. Computed
tomography (CT) pulmonary angiogram demonstrates multiple bilateral
cysts that are evenly distributed throughout the pulmonary paren-
chyma. Ground-glass nodules were noted; there were no solid paren-
chymal nodules or lymphadenopathy.
Figure 2. A 45-year-old lady presents
with acute dyspnoea. Right upper lobe
biopsy demonstrates multiple thin-walled
cysts. Areas of smooth muscle prolifera-
tion that stain focally positive for HMB-45
are noted (arrow), which is diagnostic of
lymphangioleiomyomatosis. Superim-
posed non-necrotizing granulomatous
inﬂammation (stars) is present in a lym-
phatic distribution, consistent with pul-
monary sarcoidosis.
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occur in sarcoidosis; however, this is not common and
usually occurs in the upper and hilar zones in the context
of advanced ﬁbrosis [2]. Therefore, cystic lung disease in
this case is presumed primarily due to LAM given classical
radiological features. Regarding treatment options, siroli-
mus, an mTOR inhibitor, is recommended for patients
with LAM and an FEV1 less than 70% predicted or declin-
ing lung function [3]. Obstructive spirometry in this case
is potentially confounded by a prior smoking history or
coexistent asthma. Therefore, we elected to commence
inhaler therapy, monitor regularly, and subsequently com-
mence sirolimus if there is any subsequent deterioration.
Interestingly, there are cases of LAM and sarcoidosis over-
lap in the literature and emerging data to suggest a shared
pathological mechanism between the two conditions [4,5].
It is hypothesized that dysregulation of the mTOR path-
way could also play an important role in the pathogenesis
of sarcoidosis [6]. Early data suggest that dysregulated
mTOR signalling is implicated in macrophage granuloma
formation and sarcoidosis progression [7]. Currently, there
is inadequate available data to recommend mTOR inhibi-
tor therapy in other respiratory conditions, and additional
research is required to clarify the role of these agents.
Finally, this case reinforces the persistent utility of lung
biopsy and pathology in cases of cystic lung disease. While
serological markers such as serum vascular endothelial
growth factor D (VEGF-D) are highly speciﬁc and sensi-
tive for LAM when available, if there is any clinical doubt,
then lung biopsy should be considered [3]. Importantly,
the diagnosis of sarcoidosis was made post-lung biopsy
and was not suspected prior to this.
This is an interesting case of coexistent LAM and sar-
coidosis and complements existing data that suggest a link
between mTOR dysregulation and pulmonary sarcoidosis.
Disclosure Statement
Appropriate written informed consent was obtained for
publication of this case report and accompanying images.
Acknowledgments
We acknowledge Andrew Nicholson, honorary professor
of respiratory pathology, National Heart and Lung Insti-
tute, Imperial College London, who reviewed the histopa-
thology specimens and was very helpful in reaching the
ultimate diagnosis.
References
1. Xu KF, and Lo BH. 2014. Lymphangioleiomyomatosis: dif-
ferential diagnosis and optimal management. Ther. Clin. Risk
Manag. 10:691–700.
2. Criado E, Sanchez M, Ramirez J, et al. 2010. Pulmonary sar-
coidosis: typical and atypical manifestations at high-
resolution CT with pathologic correlation. Radiographics 30:
1567–1586.
3. Mccormack FX, Gupta N, Finlay GR, et al. 2016.
ATS/JRS committee on lymphangioleomyomatosis. Ofﬁ-
cial American Thoracic Society / Japanese Respiratory
Society Clinical Practice Guidelines: lymphangioleiomyo-
matosis diagnosis and management. Am. J. Respir. Crit.
Care Med. 194:748–761.
4. Huml JP, Borkgren MW, Henley LB, et al. 1991. Pulmonary
lymphangioleiomyomatosis associated with pulmonary
parenchymal, hilar, and mediastinal Noncaseating granulo-
mas. Chest 100:1726–1728.
5. Tarjan G, Kim GJ, and Haroon Al Rasheed MR. 2016. Renal
Angiomyolipoma with sarcoid granulomas: report of a
unique case. Int. J. Surg. Pathol. 24:253–256.
6. Di Marco F, Palumbo G, Terraneo S, et al. 2017. Lymphan-
gioleiomyomatosis, multifocal micronodular pneumocyte
hyperplasia, and sarcoidosis: more pathological ﬁndings in
the same chest CT, or a single pathological pathway? BMC
Pulm. Med. 17:107.
7. Linke M, Pham HT, Katholnig K, et al. 2017. Chronic signal-
ing via the metabolic checkpoint kinase mTORC1 induces
macrophage granuloma formation and marks sarcoidosis
progression. Nat. Immunol. 18:293–302.
S. Cullivan et al. Coexistent sarcoidosis and LAM
© 2018 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd
on behalf of The Asian Paciﬁc Society of Respirology
3
